The Magnificent Seven now make up around 33% of the S&P 500, yet five of the seven are trailing the index in 2026 and three sit in the red. Growing "AI fatigue" over stretched valuations and heavy spending is likely to bring short-term volatility for Wall Street's most valuable stocks.
Investors may be losing patience with the artificial-intelligence trade that has powered Wall Street since late 2022. The Magnificent Seven — the mega-cap adopters whose market caps have swelled in the AI era — make up around 33% of the entire S&P 500's value, yet most of them are no longer leading.
Five of the seven are trailing the S&P 500 in 2026. The index is up 10.9% this year, but only Apple and Alphabet are ahead of it, gaining 16.5% and 14.8% respectively. Three of the group are in the red for the year, and there may be no quick turnaround for those stocks.
Semiconductor concerns mount
July opened with semiconductors logging their second straight losing week as more investors rotated away from the hardware powering the AI boom. Some of that money went back into the Magnificent Seven, but investors also moved toward healthcare, financials, industrials, and materials for resilience.
One of the driving concerns is a possible glut of compute capacity. Reports from Bloomberg suggest memory shortages may have peaked in Q2, which could push oversupply into the market as early as 2028. That pressure already hit Asian chip leaders: Samsung recorded a 20% decline in just five days on South Korea's KOSPI, while SK Hynix fell more than 15% in Seoul.
Stretched valuations and heavy spending
US chip stocks may face similar risks because margin debt hit a record $1.42 trillion in May, its second straight monthly increase, which could accelerate any sell-off. Meanwhile the Magnificent Seven's average forward price-to-earnings ratio sits at around 28x, ahead of the rest of the S&P 500 on average.
Spending adds another strain. The group has announced intentions to spend more than $700 billion on AI capital expenditures in 2026, a sharp step up from the prior year, and any stumble in securing that return could trigger severe disruption.
What comes next
The risk is that fatigue feeds a selling event on the scale of the KOSPI losses, where a lack of sentiment leads to sell-offs at the next significant sign of stress. That is likely to bring short-term volatility for the AI-oriented Magnificent Seven and the possibility of declines on the back of any less-than-stellar Q2 earnings reports.
Source: Benzinga
Trading involves risk.
Risk Disclaimer
